Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

ANI Pharma Inc 210 Main Street West Baudette MN 56623 USA

www.anipharmaceuticals.com Employees: 897 P: 218-634-3500

Sector:

Medical

Description:

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.

Key Statistics

Overview:

Market Capitalization, $K 1,916,380
Enterprise Value, $K 2,114,620
Shares Outstanding, K 22,469
Float, K 19,975
% Float 88.90%
Short Interest, K 2,668
Short Float 11.88%
Days to Cover 6.85
Short Volume Ratio 0.79
% of Insider Shareholders 11.10%
% of Institutional Shareholders 76.05%

Financials:

Annual Sales, $ 614,380 K
Annual Net Income, $ -18,520 K
Last Quarter Sales, $ 227,810 K
Last Quarter Net Income, $ 26,620 K
EBIT, $ 163,340 K
EBITDA, $ 244,670 K

Growth:

1-Year Return 50.62%
3-Year Return 102.97%
5-Year Return 165.78%
5-Year Revenue Growth 197.45%
5-Year Earnings Growth -10.09%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.04 on 11/07/25
Next Earnings Date 02/27/26
Earnings Per Share ttm 5.74
EPS Growth vs. Prev Qtr 18.84%
EPS Growth vs. Prev Year 57.69%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 07/18/13

ANIP Ratios

Ratio
Price/Earnings ttm 14.81
Price/Earnings forward 12.69
Price/Earnings to Growth N/A
Return-on-Equity % 26.73%
Return-on-Assets % 8.86%
Profit Margin % -3.01%
Debt/Equity 0.62
Price/Sales 2.12
Price/Cash Flow 11.19
Price/Book 3.78
Book Value/Share 22.51
Interest Coverage -0.26
60-Month Beta 0.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar